Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
04. September 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9552
Articles 1 - 20 / 191035
Inflammatory bowel disease and prostate cancer: from epidemiological controversy to mechanistic hypotheses.
Front Immunol
Yu T, Zhang L, Li D, Wang Y.
PMID: 42694773 [PubMed - indexed for MEDLINE]
Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential.
Front Cell Infect Microbiol
Sheng Z, Zhu J, Sun J, Zeng S, Ding J, Zhang Z.
PMID: 42694772 [PubMed - indexed for MEDLINE]
Treatment utilisation for Aboriginal and Torres Strait Islander people diagnosed with prostate cancer in Australia: a population-based study.
Lancet Reg Health West Pac
Yap ML, Gabriel G, Descallar J, Anderson S, Delaney GP, Do V, Murray R, Wong K, Woo HH, Griffiths K, Bennett-Brook K, Coombes J.
PMID: 42694732 [PubMed]
Nuclear Protein in Testis (NUT) Carcinoma: Diagnostic Challenges in a Patient Requiring Rescue Venovenous Extracorporeal Membrane Oxygenation.
Cureus
Lien IC, Bhyravabhotla K, Elsayad MM, Jani P, Dinh K.
PMID: 42694693 [PubMed]
Dietary Polyphenol Acteoside-Related Molecular Signatures in Clear Cell Renal Cell Carcinoma: Multi-Omics Profiling and Functional Validation of IMPDH1.
Food Sci Nutr
Chen X, Zhang D, Ji Z, Sun S, Wang J, Shen S, Zhu J.
PMID: 42694600 [PubMed]
Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review.
Ther Adv Urol
Ito W, Tachibana I.
PMID: 42694519 [PubMed]
Performance of Machine Learning Models Based on Medical Imaging in Predicting Pathological Grade of Clear Cell Renal Cell Carcinoma.
Cancer Med
Wang Y, Song Z, Hou Z, Chen Y, Liu S, Chen C, Guan H, Pang Z, Yan S, Zhang Z, Tu R, Zhu G, Zeng X, Fan B.
PMID: 42693958 [PubMed - indexed for MEDLINE]
Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation.
Clin Genitourin Cancer
Mathews P, Neiditz H, Hollenbeck P, Rajkumar J, Schoen MW, Pachynski RK, Knoche E.
PMID: 42692965 [PubMed - as supplied by publisher]
A Quantitative Nomogram Integrating IVIM-derived True Diffusion Coefficient and PSAD for Predicting Clinically Significant Prostate Cancer: Comparison With PI-RADS-based Assessment.
Acad Radiol
Wang X, Li Y, Chen Z, Shan C, Wu J, Chen Y.
PMID: 42692876 [PubMed - as supplied by publisher]
Optimizing the therapeutic ratio of PSMA-PET-guided para-aortic radiotherapy for prostate cancer: A systematic review and structured quantitative synthesis.
J Med Imaging Radiat Sci
Samai N, Berremdani A.
PMID: 42691517 [PubMed - as supplied by publisher]
Regional Variation in Bladder Cancer Clinical Trial Availability in the US.
JAMA Netw Open
Shah KU, Jaime-Casas S, Agarwal R, Zhang G, Li X, Abreu de Goes V, Castro DV, Mercier B, Simon R, Dickter S, Lau LM, Goud J, Dukkipati A, Fann J, Lau L, Lee J, Shah K, Swarat E, Zugman M, Dizman N, Moradi A, Barragan-Carrillo R, Tripathi A, Nguyen CB, Chehrazi-Raffle A, Pal SK.
PMID: 42690658 [PubMed - indexed for MEDLINE]
Value of 3D-presumed circular area ratio in MRI assessment of benign prostatic hyperplasia.
World J Urol
Yang J, Shi W, Xie H, Zhang Y, Li J, Guo G, Yuan M, Zou Z, Mu X.
PMID: 42690423 [PubMed - indexed for MEDLINE]
Interpretable machine learning for individualized survival prediction in node-positive, non-metastatic prostate cancer: a population-based study.
Aging Male
Bao E, Chai Y, Yang Y, Dai S, Wang C, Zhou X, Li X, Li Y, Yang Q, Liu J.
PMID: 42690326 [PubMed - indexed for MEDLINE]
Global burden and inequality of childhood kidney cancer (1990-2050): a systematic analysis for the global burden of disease study 2021.
World J Urol
Sun Y, Xu Q, Dai X, Li S, Chu J, Ma M, Wang P, Liu L.
PMID: 42690270 [PubMed - indexed for MEDLINE]
Dual-Matrix Platform for Highly Specific Multi-Omics Profiling of Renal Cell Carcinoma.
Anal Chem
Zhang Y, Zhang M, Gao M, Deng C, Jiang S, Sun N.
PMID: 42689576 [PubMed - indexed for MEDLINE]
2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.
J Urol
Clark PE, Holzbeierlein J, Chang SS, Djaladat H, Kim SK, Kirkby E, Kukreja JB, Souter LH.
PMID: 42689553 [PubMed - as supplied by publisher]
Sexual life and intimate relationship experience among bladder cancer patients: a systematic review and qualitative meta-synthesis.
Front Public Health
Tan S, Nie C, Yang S, Dai C, Li Y.
PMID: 42688463 [PubMed - indexed for MEDLINE]
Escaping the "PSA Test Loop": How PSA Testing Overshadows Male LUTS Treatment and Management in Primary Care.
Eur Urol Focus
Wheeler JR, Cotterill N, Worthington J, Lane A, Ridd MJ, Mahmud A, Drake MJ.
PMID: 42686465 [PubMed - as supplied by publisher]
Wilms Tumor.
Surg Oncol Clin N Am
Murphy AJ, Santiago T, Cost NG.
PMID: 42686227 [PubMed - indexed for MEDLINE]
Definitive Chemoradiotherapy Versus Radical Cystectomy for Small Cell Carcinoma of the Bladder: A Multicenter Retrospective Study.
Clin Genitourin Cancer
Kim HJ, Park W, Kim YS, Kim JS, Kim Y, Kim TG, Lee SU, Chang AR, Cho J.
PMID: 42685655 [PubMed - as supplied by publisher]
Articles 1 - 20 / 191035
Page 1 of 9552
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy